Enrico Baraldi, Christine Årdal, Emil Aho, Gabriel-Adrian Popescu, Tsegaye Melaku
{"title":"The multifaceted nature of lack of access to antibiotics: types of shortage and specific causes, consequences, and solutions.","authors":"Enrico Baraldi, Christine Årdal, Emil Aho, Gabriel-Adrian Popescu, Tsegaye Melaku","doi":"10.1016/j.cmi.2024.11.012","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Maintaining access to a broad range of old and new antibiotics is increasingly difficult due to supply, market and demand issues. Next to immediate negative consequences for individual patients and healthcare systems, antibiotic unavailability can accelerate resistance development due to unmotivated use of suboptimal broad-spectrum antibiotics.</p><p><strong>Objectives: </strong>While academics and policymakers agree that lack of access to antibiotics is a major public challenge, there are widely different situations of lack of access which are not always clearly identified. Therefore, this paper aims to clarify potential confusion by delving into four different types of lack of access, their specific causes, consequences and potential solutions.</p><p><strong>Sources: </strong>The paper builds on a narrative review of academic and policy literature about lack of access to antibiotics and potential solutions to address it.</p><p><strong>Content: </strong>We discuss causes as well as economic and clinical consequences of four different types of antibiotic unavailability: short-term shortages, long-term shortages, deregistrations and lack of registration. The discussion is supported by examples from Norway, Romania and Ethiopia, three countries characterized by clearly different market sizes and ability to pay. Common causes for all types of lack access include unattractive markets, dependence on few suppliers and insufficient communication, whereas other causes are specific to one type (e.g., insufficient inventories cause short-term shortages or regulatory complexity hinders registration). Longer lack of access entails more serious clinical consequences and higher risk of resistance development, but may not correspondingly increase costs in the long-term if alternatives are identified.</p><p><strong>Implications: </strong>It is essential to understand the type of unavailability at hand because no single solution can address all types. For instance, stockpiling addresses short-term shortages, but not long-term ones or deregistrations. However, supply chain transparency and pooled procurement are remedies that support other solutions and can cope with several types of lack of access.</p>","PeriodicalId":10444,"journal":{"name":"Clinical Microbiology and Infection","volume":" ","pages":""},"PeriodicalIF":10.9000,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Microbiology and Infection","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.cmi.2024.11.012","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Maintaining access to a broad range of old and new antibiotics is increasingly difficult due to supply, market and demand issues. Next to immediate negative consequences for individual patients and healthcare systems, antibiotic unavailability can accelerate resistance development due to unmotivated use of suboptimal broad-spectrum antibiotics.
Objectives: While academics and policymakers agree that lack of access to antibiotics is a major public challenge, there are widely different situations of lack of access which are not always clearly identified. Therefore, this paper aims to clarify potential confusion by delving into four different types of lack of access, their specific causes, consequences and potential solutions.
Sources: The paper builds on a narrative review of academic and policy literature about lack of access to antibiotics and potential solutions to address it.
Content: We discuss causes as well as economic and clinical consequences of four different types of antibiotic unavailability: short-term shortages, long-term shortages, deregistrations and lack of registration. The discussion is supported by examples from Norway, Romania and Ethiopia, three countries characterized by clearly different market sizes and ability to pay. Common causes for all types of lack access include unattractive markets, dependence on few suppliers and insufficient communication, whereas other causes are specific to one type (e.g., insufficient inventories cause short-term shortages or regulatory complexity hinders registration). Longer lack of access entails more serious clinical consequences and higher risk of resistance development, but may not correspondingly increase costs in the long-term if alternatives are identified.
Implications: It is essential to understand the type of unavailability at hand because no single solution can address all types. For instance, stockpiling addresses short-term shortages, but not long-term ones or deregistrations. However, supply chain transparency and pooled procurement are remedies that support other solutions and can cope with several types of lack of access.
期刊介绍:
Clinical Microbiology and Infection (CMI) is a monthly journal published by the European Society of Clinical Microbiology and Infectious Diseases. It focuses on peer-reviewed papers covering basic and applied research in microbiology, infectious diseases, virology, parasitology, immunology, and epidemiology as they relate to therapy and diagnostics.